Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.55% | 3.03% | -20.25% | -50.73% | 20.13% |
| Total Depreciation and Amortization | -- | 0.00% | -50.00% | 0.00% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.36% | -97.50% | 940.00% | 100.00% | 202.99% |
| Change in Net Operating Assets | 3,268.18% | -30.63% | -90.24% | 115.53% | -93.62% |
| Cash from Operations | 13.29% | -17.69% | -59.12% | 9.81% | 16.94% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -54.46% | 26.32% | 100.00% | -79.55% | 62.03% |
| Issuance of Common Stock | 26,005.88% | -100.00% | -27.05% | -49.34% | -99.25% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -140.00% | -353.33% | -194.96% | 22.28% | 82.99% |
| Cash from Financing | 3,205.97% | -111.46% | -32.64% | -54.41% | -107.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 161.84% | -203.67% | -97.52% | -226.48% | -79.78% |